Standards; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
6-Aminoquinazoline has an effect on TRPC1-mediated neuronal store-operated Ca entry pathway, which delayed the progression of Huntington's disease motor phenotype in Drosophila, making it a therapeutic target for Huntington's disease treatment.